Cargando…

Prevalence of Anemia in Pediatric IBD Patients and Impact on Disease Severity: Results of the Pediatric IBD-Registry CEDATA-GPGE®

AIM: To determine the prevalence of anemia and its association with disease severity in children and adolescents with IBD. METHODS: CEDATA-GPGE is a registry for pediatric patients with IBD in Germany and Austria from 90 specialized centers. As markers of disease severity, analysis included patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Laffolie, Jan, Laass, Martin W., Scholz, Dietmar, Zimmer, Klaus-Peter, Buderus, Stephan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735663/ https://www.ncbi.nlm.nih.gov/pubmed/29358946 http://dx.doi.org/10.1155/2017/8424628

Ejemplares similares

Predicting complications in pediatric Crohn's disease patients followed in CEDATA-GPGE registry
por: Klamt, Juliane, et al.
Publicado: (2023)

Isolated Crohn's Colitis: Is Localization Crucial? Characteristics of Pediatric Patients From the CEDATA–GPGE Registry
por: Elonen, Lotta, et al.
Publicado: (2022)

Occurrence of Thromboembolism in Paediatric Patients With Inflammatory Bowel Disease: Data From the CEDATA-GPGE Registry
por: De Laffolie, Jan, et al.
Publicado: (2022)

Machine Learning Classification of Inflammatory Bowel Disease in Children Based on a Large Real-World Pediatric Cohort CEDATA-GPGE® Registry
por: Schneider, Nicolas, et al.
Publicado: (2021)

Implementation of exclusive enteral nutrition in pediatric patients with Crohn’s disease—results of a survey of CEDATA-GPGE reporting centers
por: Peters, Sarah, et al.
Publicado: (2022)

How can patient registries facilitate guideline-based healthcare? A retrospective analysis of the CEDATA-GPGE registry for pediatric inflammatory bowel disease
por: Leiz, M., et al.
Publicado: (2023)

Diagnostic delay in children with inflammatory bowel disease in the German-Austrian patient registry CEDATA-GPGE 2014–2018
por: Leiz, Maren, et al.
Publicado: (2022)

Significant advantages for first line treatment with TNF-alpha inhibitors in pediatric patients with inflammatory bowel disease – Data from the multicenter CEDATA-GPGE registry study
por: Claßen, Merle, et al.
Publicado: (2022)

Incidence trends of pediatric onset inflammatory bowel disease in the years 2000–2009 in Saxony, Germany–first results of the Saxon Pediatric IBD Registry
por: Kern, Ivana, et al.
Publicado: (2021)

Fecal Lactoferrin: Reliable Biomarker for Intestinal Inflammation in Pediatric IBD
por: Buderus, Stephan, et al.
Publicado: (2015)

Current and projected incidence trends of pediatric-onset inflammatory bowel disease in Germany based on the Saxon Pediatric IBD Registry 2000–2014 –a 15-year evaluation of trends
por: Kern, Ivana, et al.
Publicado: (2022)

Molecular Genetic Architecture of Monogenic Pediatric IBD Differs from Complex Pediatric and Adult IBD
por: Jezernik, Gregor, et al.
Publicado: (2020)

Prognostic Factors of Biologic Therapy in Pediatric IBD
por: Buczyńska, Anna, et al.
Publicado: (2022)

Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort study
por: Bon, Lorenz, et al.
Publicado: (2019)

Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2020)

Biosimilars in Pediatric IBD: Updated Considerations for Disease Management
por: Dipasquale, Valeria, et al.
Publicado: (2022)

The Impact of Vedolizumab on COVID-19 Outcomes Among Adult IBD Patients in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2021)

Improving pediatric Inflammatory Bowel Disease (IBD) follow-up
por: Dykes, Dana, et al.
Publicado: (2016)

The Oral Microbiome in Pediatric IBD: A Source of Pathobionts or Biomarkers?
por: Elmaghrawy, Khalid, et al.
Publicado: (2021)

Fr494 THE IMPACT OF VEDOLIZUMAB THERAPY ON COVID-19 OUTCOMES IN ADULT IBD PATIENTS IN THE SECURE-IBD REGISTRY
por: Agrawal, Manasi, et al.
Publicado: (2021)

Application of Comparative Transcriptional Genomics to Identify Molecular Targets for Pediatric IBD
por: Fang, Kai, et al.
Publicado: (2015)

Telemedicine and Integrated Multidisciplinary Care for Pediatric IBD Patients: A Review
por: Potthoff, Lauren M.
Publicado: (2021)

Bridges to excellence quality indicators in inflammatory bowel disease (IBD): differences between IBD and non-IBD gastroenterologists
por: Bilal, Mohammad, et al.
Publicado: (2017)

Pediatric GI Health Care Professionals’ Perceptions of and Engagement With Psychosocial Providers in Pediatric IBD Care
por: David, Jennie G., et al.
Publicado: (2023)

Clinical course of new-onset Crohn’s disease in children and adolescents in dependency of age, initial location, initial severity level and therapy over the period 2000–2014 based on the Saxon Pediatric IBD-Registry in Germany
por: Dong, Fan, et al.
Publicado: (2023)

COVID-19 in IBD: The experience of a single tertiary IBD center
por: Rizzello, Fernando, et al.
Publicado: (2021)

Transitioning the Adolescent with IBD from Pediatric to Adult Care: A Review of the Literature
por: Bollegala, Natasha, et al.
Publicado: (2015)

Biologic therapy is associated with a mild decrease in the rate of hospitalizations in pediatric IBD
por: Berkovitch, Gil, et al.
Publicado: (2021)

Identifying Microbiome Dynamics in Pediatric IBD: More than a Family Matter
por: Dovrolis, Nikolas, et al.
Publicado: (2023)

Zebrafish model for IBD
Publicado: (2011)

IBD considerations in spondyloarthritis
por: Di Jiang, Caroline, et al.
Publicado: (2020)

The Impact of PPARγ Genetic Variants on IBD Susceptibility and IBD Disease Course
por: Mwinyi, Jessica, et al.
Publicado: (2012)

Risk of Adverse Pregnancy Outcomes for Women with IBD in an Expert IBD Antenatal Clinic
por: Lever, Gillian, et al.
Publicado: (2022)

Bowel Location Rather Than Disease Subtype Dominates Transcriptomic Heterogeneity in Pediatric IBD
por: Venkateswaran, Suresh, et al.
Publicado: (2018)

Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients
por: Spencer, Elizabeth A, et al.
Publicado: (2021)

Inflammatory Bowel Disease in Hispanics: The University of Puerto Rico IBD Registry
por: Torres, Esther A., et al.
Publicado: (2012)

36. Jahrestagung der GPGE
por: Facharztmagazine, Redaktion
Publicado: (2021)

37. Jahrestagung der GPGE
Publicado: (2022)

38. Jahrestagung der GPGE
Publicado: (2023)

Prevalence of serum celiac antibody in patients with IBD in Japan
por: Watanabe, Chikako, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_e87c7beb4ik1vmt4ou28ubhesn